Every 10-Q that HEALTHIER CHOICES MGMT (HCMC) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 10-Q covers the quarterly report filed between annual reports, so if you follow HCMC and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full HCMC filings page.
Healthier Choices Management Corp. (HCMC) reported essentially no operating revenue for the three and six months ended June 30, 2026, as legacy vape retail operations remain closed and new products have not yet launched. For the quarter, HCMC generated a small net income of $75,236 versus a loss of $1,991,797 a year earlier, driven almost entirely by a sharp reduction in operating expenses and a $328,373 reclassification of payroll costs to former subsidiary HCWC after termination of a Transition Services Agreement. For the six months, the net loss narrowed to $711,559 from $4,175,473.
Liquidity remains tight: at June 30, 2026, HCMC held $1.2 million in cash and had negative working capital of $0.7 million, with total assets of $1.5 million and a stockholders’ deficit of $1.7 million. The company depends on external financing, including a new $5.0 million unsecured revolving credit facility with Sabby Volatility Warrant Master Fund, of which $500,000 was drawn, and a $50,000 12% convertible note that can convert at $0.00009 per share. As of August 19, 2026, there were 527.2 billion common shares outstanding, with substantial additional potential dilution from preferred stock, options, and warrants. Management believes existing cash plus available borrowing capacity can fund operations for at least 12 months, but ongoing losses and reliance on financing remain significant risks.
The business strategy centers on monetizing intellectual property, particularly Q‑Cup™ and related patents, and launching the Quitcubes product using the NatureTine™ ingredient under a 2025 distribution agreement. The Quitcubes launch was delayed, producing no sales in the first half of 2026; management now targets a third‑quarter 2026 launch, while cautioning there is no assurance of material revenue or cash flow. Subsequent to quarter end, HCMC announced a digital asset initiative using its RAGE platform and the planned acquisition of two tokens; as of the reporting date no tokens had been delivered and no asset was recorded. The company also continues to pursue a patent infringement case against R.J. Reynolds Vapor Company after an adverse Patent Trial and Appeal Board decision, which HCMC has appealed. Internal control over financial reporting was assessed as ineffective, with material weaknesses in segregation of duties and IT controls; remediation efforts, including additional hiring and stronger IT policies, are underway.
Healthier Choices Management Corp. reported a net loss of $786,795 for the three months ended March 31, 2026, with no net sales as product launches were delayed. Operating expenses fell sharply to $806,624 from $2.17M a year earlier, mainly due to lower stock-based compensation and professional fees.
Cash and cash equivalent were about $1.1M with negative working capital of $0.8M, so the company is relying on a new $5M Sabby revolving credit facility, of which $500,000 has been drawn. Management expects a June 2026 launch of the Quitcubes product line but cautions there is no assurance it will generate material revenue.
The company continues to carry a stockholders’ deficit and recurring losses, and its key patent portfolio faced a setback when the Patent Trial and Appeal Board issued a decision in favor of R.J. Reynolds in an inter partes review, which HCMC plans to appeal. Management also reports material weaknesses in internal control over financial reporting, including segregation of duties and IT control deficiencies, and is implementing remediation plans.
Healthier Choices Management Corp. (HCMC) filed its Q3 2025 report, showing continued operating losses and tight liquidity. Net sales were minimal, while operating costs remained high, resulting in a net loss from continuing operations of $2.08 million for the quarter and $6.25 million year‑to‑date. Cash and cash equivalent were $1.12 million with total assets of $1.53 million, and current liabilities of $4.86 million, reflecting negative working capital.
The company reported a stockholders’ deficit of $(4.44) million and noted reliance on related‑party funding under a transition services framework following the HCWC spin‑off. As of November 6, 2025, 481,266,632,384 common shares were outstanding. Management believes cash on hand and the ability to draw on a $5 million line of credit will cover obligations for at least twelve months. HCMC disclosed material weaknesses in internal controls (segregation of duties and IT controls) and paid a previously accrued $1.5 million litigation settlement. A subsequent amendment extended preferred-stock agreement timelines to April 1, 2027.